ifosfamide has been researched along with Nephrotic Syndrome in 4 studies
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide, an alkylating agent was used successfully in the treatment of children with steroid sensitive nephrotic syndrome with minimal changes." | 7.65 | [Ifosfamide in the treatment of nephrotic syndrome (author's transl)]. ( Daigeler, C; Gekle, D, 1977) |
| "Ifosfamide, an alkylating agent was used successfully in the treatment of children with steroid sensitive nephrotic syndrome with minimal changes." | 3.65 | [Ifosfamide in the treatment of nephrotic syndrome (author's transl)]. ( Daigeler, C; Gekle, D, 1977) |
| "Ifosfamide is a well known prodrug for cancer treatment with cytochrome P450 metabolism." | 1.35 | New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity. ( Bourget, P; Deroussent, A; Martens, T; Mercier, L; Munier, F; Paci, A; Prost, E; Re, M; Royer, J; Storme, T; Vassal, G, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dholaria, B | 1 |
| Patel, RJ | 1 |
| Sluzevich, JC | 1 |
| Ailawadhi, S | 1 |
| Roy, V | 1 |
| Yılmaz, S | 1 |
| Özçakar, ZB | 1 |
| Taktak, A | 1 |
| Kiremitçi, S | 1 |
| Ensari, A | 1 |
| Dinçaslan, H | 1 |
| Yalçınkaya, F | 1 |
| Storme, T | 1 |
| Deroussent, A | 1 |
| Mercier, L | 1 |
| Prost, E | 1 |
| Re, M | 1 |
| Munier, F | 1 |
| Martens, T | 1 |
| Bourget, P | 1 |
| Vassal, G | 1 |
| Royer, J | 1 |
| Paci, A | 1 |
| Gekle, D | 1 |
| Daigeler, C | 1 |
4 other studies available for ifosfamide and Nephrotic Syndrome
| Article | Year |
|---|---|
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclo | 2017 |
Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 2016 |
New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
Topics: Animals; Antineoplastic Agents, Alkylating; Biotransformation; Cells, Cultured; Humans; Ifosfamide; | 2009 |
[Ifosfamide in the treatment of nephrotic syndrome (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Ifosfamide; Infant; Male; Nep | 1977 |